Neurology

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases
Vietzen, H., Kühner, L. M., Berger, S. M., Reinecke, R., Rostásy, K., Saucke, H., Kauth, F., Koukou, G., Sommer, S., Wendel, E. M., Graninger, M., Camp, J. V., Waubant, E. L., Casper, T. C., Benson, L. A., Chitnis, T., Aaen, G. S., Mar, S., Weinstock-Guttman, B. & Lotze, T. E. & 14 others, Krupp, L. B., Lassmann, H., Weidner, L., Pistorius, C., Jungbauer, C., Ponleitner, M., Reindl, M., Kornek, B., Breu, M., Bsteh, G., Höftberger, R., Berger, T., Puchhammer-Stöckl, E. & Rommer, P., 2026, (Accepted/In press) In: JAMA Neurology.
Research output: Contribution to journal › Article › peer-review

Open Access
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis
the US Network of Pediatric MS Centers, Mar 2026, In: Annals of Neurology. 99, 3, p. 715-729 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
The impact of cardiovascular disease on Parkinson's disease: Findings from the PPMI study
Vakhshoori, M., Bondariyan, N., Jones, J., Mari, Z., Pedouim, F. & Dashtipour, K., Mar 2026, In: Parkinsonism and Related Disorders. 144, 108210.
Research output: Contribution to journal › Article › peer-review

Research units